ExxonMobil (XOM)

Cost of Revenue

$88.90B

Quarterly · Period ending: · USD

XOM logo

XOM Cost of Revenue

Latest reported$88.90B
XOM Quarterly Cost of Revenue ($0.00 → $88.90B)
High-resolution chart · PNG

XOM cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ExxonMobil Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
88,895,000,000
51,802,000,000
64,923,000,000
64,646,000,000
61,530,000,000
62,573,000,000
63,811,000,000
67,400,000,000
69,790,000,000
61,504,000,000
63,985,000,000
66,187,000,000
60,700,000,000
59,683,000,000
66,190,000,000
77,156,000,000
80,750,000,000
71,512,000,000
61,933,000,000
53,454,000,000
50,752,000,000
45,667,000,000
62,332,000,000
36,036,000,000
25,880,000,000
46,199,000,000
49,177,000,000
49,011,000,000
53,095,000,000
48,342,000,000
51,985,000,000
55,531,000,000
54,834,000,000
49,249,000,000
34,821,000,000
44,264,000,000
42,906,000,000
42,444,000,000
50,400,000,000
45,786,000,000
45,462,000,000
37,848,000,000
46,850,000,000
51,245,000,000
56,963,000,000
51,258,000,000
65,917,000,000
81,900,000,000
84,844,000,000
79,562,000,000
83,780,000,000
85,972,000,000
81,913,000,000
80,787,000,000
97,196,000,000
85,917,000,000
88,057,000,000
92,010,000,000
86,018,000,000
87,972,000,000
79,769,000,000
77,933,000,000
92,376,000,000
65,029,000,000
63,791,000,000
62,035,000,000
55,342,000,000
49,786,000,000
51,638,000,000
41,679,000,000
47,926,000,000
83,176,000,000
96,637,000,000
78,638,000,000
69,391,000,000
60,206,000,000
55,658,000,000
47,597,000,000
50,183,000,000
56,773,000,000
55,772,000,000
50,527,000,000
56,944,000,000
59,130,000,000
51,358,000,000
45,570,000,000
45,254,000,000
43,156,000,000
38,894,000,000
36,243,000,000
33,857,000,000
32,777,000,000
29,729,000,000
33,565,000,000
30,242,000,000
30,182,000,000
27,060,000,000
22,008,000,000
23,223,000,000
27,638,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.